Antwerp radiotherapy centre chooses TomoTherapy cancer treatment system
7 June 2007 Madison, Wis., USA. The new University Radiotherapy Centre of
Antwerp has chosen the TomoTherapy Hi·Art treatment system for providing
radiation therapy, and the Centre will serve as a European training facility
for TomoTherapy Incorporated (NASDAQ: TTPY).
Hospitals participating in the Centre include University Hospital Antwerp and the Antwerp
City Hospital Network.
Two Hi·Art treatment systems have been installed on-site at
University Hospital Antwerp. Through the University Radiotherapy Center,
both member hospitals will use Hi·Art treatment systems to treat cancer
patients with advanced image-guided, intensity-modulated radiation therapy (IG/IMRT).
And, through collaboration with TomoTherapy, the machines will also be
available for training physicians, hospital staff and TomoTherapy employees
while still providing uninterrupted patient care. International Marketing Manager Chris Hasler
said, “This partnership makes it possible to combine training and patient
care in a unique setting. The training
component demonstrates our commitment to the European market and to customer
support.” “The training centre is of
particular importance for Antwerp University Hospital,” says Antwerp
University Hospital Head of Communication Tom Meulenbergs.
“As an academic centre of excellence, it places high value on offering the
best possible patient care through continuous innovation. The combination of
training and treatment centres fits seamlessly into this picture.”
Creation of a training centre based in Europe is part of TomoTherapy’s
vision for global training. The centre will serve as a regional satellite of
the International Technical Training Center at company headquarters in
Madison, Wisconsin. To top
|
